118 related articles for article (PubMed ID: 29028461)
1. Antibiotic-Impregnated Central Venous Catheters Do Not Change Antibiotic Resistance Patterns.
Turnbull IR; Buckman SA; Horn CB; Bochicchio GV; Mazuski JE
Surg Infect (Larchmt); 2018 Jan; 19(1):40-47. PubMed ID: 29028461
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Trial.
Bonne S; Mazuski JE; Sona C; Schallom M; Boyle W; Buchman TG; Bochicchio GV; Coopersmith CM; Schuerer DJ
J Am Coll Surg; 2015 Sep; 221(3):739-47. PubMed ID: 26199017
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic-impregnated catheters associated with significant decrease in nosocomial and multidrug-resistant bacteremias in critically ill patients.
Hanna HA; Raad II; Hackett B; Wallace SK; Price KJ; Coyle DE; Parmley CL;
Chest; 2003 Sep; 124(3):1030-8. PubMed ID: 12970034
[TBL] [Abstract][Full Text] [Related]
4. In vitro exposure of bacteria to antimicrobial impregnated-central venous catheters does not directly lead to the emergence of antimicrobial resistance.
Munson EL; Heard SO; Doern GV
Chest; 2004 Nov; 126(5):1628-35. PubMed ID: 15539737
[TBL] [Abstract][Full Text] [Related]
5. CATheter Infections in CHildren (CATCH): a randomised controlled trial and economic evaluation comparing impregnated and standard central venous catheters in children.
Harron K; Mok Q; Dwan K; Ridyard CH; Moitt T; Millar M; Ramnarayan P; Tibby SM; Muller-Pebody B; Hughes DA; Gamble C; Gilbert RE
Health Technol Assess; 2016 Mar; 20(18):vii-xxviii, 1-219. PubMed ID: 26935961
[TBL] [Abstract][Full Text] [Related]
6. Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection.
Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Orlando F; Mocchegiani F; Silvestri C; Licci A; Chiodi L; Lukasiak J; Saba V; Scalise G
Peptides; 2006 Jun; 27(6):1210-6. PubMed ID: 16289474
[TBL] [Abstract][Full Text] [Related]
7. Five-Lumen Antibiotic-Impregnated Femoral Central Venous Catheters in Severely Burned Patients: An Investigation of Device Utility and Catheter-Related Bloodstream Infection Rates.
Friedman BC; Mian MA; Mullins RF; Hassan Z; Shaver JR; Johnston KK
J Burn Care Res; 2015; 36(4):493-9. PubMed ID: 25407386
[TBL] [Abstract][Full Text] [Related]
8. The use of minocycline-rifampin coated central venous catheters for exchange of catheters in the setting of staphylococcus aureus central line associated bloodstream infections.
Chaftari AM; El Zakhem A; Jamal MA; Jiang Y; Hachem R; Raad I
BMC Infect Dis; 2014 Sep; 14():518. PubMed ID: 25253042
[TBL] [Abstract][Full Text] [Related]
9. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.
Darouiche RO; Raad II; Heard SO; Thornby JI; Wenker OC; Gabrielli A; Berg J; Khardori N; Hanna H; Hachem R; Harris RL; Mayhall G
N Engl J Med; 1999 Jan; 340(1):1-8. PubMed ID: 9878638
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters.
Hanna H; Bahna P; Reitzel R; Dvorak T; Chaiban G; Hachem R; Raad I
Antimicrob Agents Chemother; 2006 Oct; 50(10):3283-8. PubMed ID: 17005806
[TBL] [Abstract][Full Text] [Related]
11. Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial.
León C; Ruiz-Santana S; Rello J; de la Torre MV; Vallés J; Alvarez-Lerma F; Sierra R; Saavedra P; Alvarez-Salgado F;
Intensive Care Med; 2004 Oct; 30(10):1891-9. PubMed ID: 15278273
[TBL] [Abstract][Full Text] [Related]
12. Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials.
Falagas ME; Fragoulis K; Bliziotis IA; Chatzinikolaou I
J Antimicrob Chemother; 2007 Mar; 59(3):359-69. PubMed ID: 17255143
[TBL] [Abstract][Full Text] [Related]
13. Prolonged bacterial exposure to minocycline/rifampicin-impregnated vascular catheters does not affect antimicrobial activity of catheters.
Aslam S; Darouiche RO
J Antimicrob Chemother; 2007 Jul; 60(1):148-51. PubMed ID: 17525051
[TBL] [Abstract][Full Text] [Related]
14. Impregnated central venous catheters for prevention of bloodstream infection in children (the CATCH trial): a randomised controlled trial.
Gilbert RE; Mok Q; Dwan K; Harron K; Moitt T; Millar M; Ramnarayan P; Tibby SM; Hughes D; Gamble C;
Lancet; 2016 Apr; 387(10029):1732-42. PubMed ID: 26946925
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with minocycline and rifampin-impregnated central venous catheters in bone marrow transplantation recipients: efficacy and low risk of developing staphylococcal resistance.
Chatzinikolaou I; Hanna H; Graviss L; Chaiban G; Perego C; Arbuckle R; Champlin R; Darouiche R; Samonis G; Raad I
Infect Control Hosp Epidemiol; 2003 Dec; 24(12):961-3. PubMed ID: 14700414
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study.
Chatzinikolaou I; Finkel K; Hanna H; Boktour M; Foringer J; Ho T; Raad I
Am J Med; 2003 Oct; 115(5):352-7. PubMed ID: 14553869
[TBL] [Abstract][Full Text] [Related]
17. Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients.
Chelliah A; Heydon KH; Zaoutis TE; Rettig SL; Dominguez TE; Lin R; Patil S; Feudtner C; St John KH; Bell LM; Coffin SE
Pediatr Infect Dis J; 2007 Sep; 26(9):816-20. PubMed ID: 17721377
[TBL] [Abstract][Full Text] [Related]
18. New choices for central venous catheters: potential financial implications.
Shorr AF; Humphreys CW; Helman DL
Chest; 2003 Jul; 124(1):275-84. PubMed ID: 12853534
[TBL] [Abstract][Full Text] [Related]
19. Effect of nurse staffing and antimicrobial-impregnated central venous catheters on the risk for bloodstream infections in intensive care units.
Alonso-Echanove J; Edwards JR; Richards MJ; Brennan P; Venezia RA; Keen J; Ashline V; Kirkland K; Chou E; Hupert M; Veeder AV; Speas J; Kaye J; Sharma K; Martin A; Moroz VD; Gaynes RP
Infect Control Hosp Epidemiol; 2003 Dec; 24(12):916-25. PubMed ID: 14700407
[TBL] [Abstract][Full Text] [Related]
20. Incidence of catheter-associated bloodstream infection after introduction of minocycline and rifampin antimicrobial-coated catheters in a pediatric burn population.
Weber JM; Sheridan RL; Fagan S; Ryan CM; Pasternack MS; Tompkins RG
J Burn Care Res; 2012; 33(4):539-43. PubMed ID: 22210071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
